Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course

1988 ◽  
Vol 8 (2) ◽  
pp. 61-65 ◽  
Author(s):  
A. J. G. Swaak ◽  
H. Han ◽  
A. van Rooyen ◽  
M. Pillay ◽  
C. E. Hack
Keyword(s):  
Rheumatoid Arthritis ◽  
Complement C3 ◽  
Disease Course ◽  
C3 Metabolism

Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course

1986 ◽  
Vol 6 (5) ◽  
pp. 221-226 ◽  
Author(s):  
A. J. G. Swaak ◽  
A. van Rooyen ◽  
C. Vogelaar ◽  
M. Pillay ◽  
E. Hack
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Complement C3 ◽  
Disease Course ◽  
Systemic Lupus ◽  
C3 Metabolism

scholarly journals Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.

1978 ◽  
Vol 37 (1) ◽  
pp. 18-23 ◽  
Author(s):  
M F Shadforth ◽  
D C McNaughton
Keyword(s):  
Rheumatoid Arthritis ◽  
Complement C3 ◽  
C3 Metabolism

Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study

2018 ◽  
Vol 13 (3) ◽  
pp. 215-221 ◽  
Author(s):  
Francesco Ursini ◽  
Salvatore D`Angelo ◽  
Emilio Russo ◽  
Giorgio Ammerata ◽  
Ludovico Abenavoli ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Type 2 Diabetes ◽  
Case Control Study ◽  
Case Control ◽  
Complement C3 ◽  
Serum Complement ◽  
Control Study

scholarly journals Metabolism of the third component of complement (C3) in patients with rheumatoid arthritis

1972 ◽  
Vol 15 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Arthur Weinstein ◽  
Keith Peters ◽  
David Brown ◽  
Rodney Bluestone
Keyword(s):  
Rheumatoid Arthritis ◽  
Complement C3 ◽  
The Third ◽  
Third Component Of Complement

scholarly journals Expression of CD62P and CD154 in peripheral blood of patients with rheumatoid arthritis and their correlation with clinical indexes

2019 ◽  
Vol 17 ◽  
pp. 205873921882268
Author(s):  
Shiping Qu ◽  
Chunyi Yu ◽  
Qian Xing ◽  
Haisheng Hu ◽  
Haiyan Jin
Keyword(s):  
Rheumatoid Arthritis ◽  
Peripheral Blood ◽  
Healthy Subjects ◽  
Disease Activity Score ◽  
Control Group ◽  
Disease Course ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Erythrocyte Sedimentation ◽  
Pearson Test

The aim of this study is to investigate the expression of CD62P and CD154 in peripheral blood of patients with rheumatoid arthritis (RA) and their correlation with the clinical indexes of RA. A total of 60 RA patients diagnosed and treated in the Department of Rheumatism in our hospital from January to December 2016 were selected as the RA group, and 60 cases of healthy subjects were selected as the control group. CD62P and CD154 levels in peripheral blood were determined by flow cytometry using the FACS Vantage flow cytometer, and the correlation analysis with the clinical indexes of RA patients were conducted. The levels of CD62P and CD154 in the peripheral blood of RA group were 28.75% ± 1.48% and 26.84% ± 1.03%, respectively, which were significantly higher than those of the control group ( P < 0.05). The levels of white blood cell (WBC), platelet (PLT), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), C-reactive protein (CRP), and interleukin (IL)-37 in the RA group were significantly higher than those in the control group ( P < 0.05). Pearson test showed that CD62P and CD154 levels in the peripheral blood in the RA group were positively correlated with serum WBC, PLT, ESR, RF, CRP, IL-37, and disease activity score 28 (DAS28) ( P < 0.05), but not correlated with disease course ( P > 0.05). The expression of CD62P and CD154 in peripheral blood of patients with RA was upregulated, and their expression levels were correlated with the activity of RA and the degree of joint lesion.

Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients

2018 ◽  
Vol 37 (6) ◽  
pp. 1695-1700 ◽  
Author(s):  
Ciro Romano ◽  
Andrea Del Mastro ◽  
Ausilia Sellitto ◽  
Eleonora Solaro ◽  
Sergio Esposito ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Serum Levels ◽  
Complement C3

AB0312 Predictors of Disease Course after The Discontinuation of Biologic Therapy in Rheumatoid Arthritis Patients with Long-Term Remission

2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 1007.1-1007
Author(s):  
G. Kádár ◽  
Ά. Czibula ◽  
B. Szalay ◽  
K. Nagy ◽  
A. Pusztai ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Biologic Therapy ◽  
Disease Course

Comment on: Complement C3 and fatty liver disease in Rheumatoid arthritis patients: A cross-sectional study

2018 ◽  
Vol 48 (2) ◽  
pp. e12879
Author(s):  
Fatemeh Khosravi Shadmani ◽  
Salman Khazaei ◽  
Shiva Mansouri Hanis ◽  
Kamyar Mansori
Keyword(s):  
Rheumatoid Arthritis ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Cross Sectional Study ◽  
Complement C3 ◽  
Sectional Study ◽  
Cross Sectional

scholarly journals Q222R polymorphism in the DNAse I gene is not associated with susceptibility to rheumatoid arthritis or to disease course in an Argentine patient cohort

2016 ◽  
Vol 38 (4) ◽  
pp. 289-293 ◽  
Author(s):  
Federico M. Aranda ◽  
Silvia D. Perés Wingeyer ◽  
Gabriela Camicia ◽  
Emilce Schneeberger ◽  
Fernando Dal Pra ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Dnase I ◽  
Disease Course ◽  
Patient Cohort ◽  
I Gene

Do Disease-Modifying Antirheumatic Drugs Actually Modify Disease Course in Rheumatoid Arthritis?

1994 ◽  
Vol 1 (5) ◽  
pp. 319-322 ◽  
Author(s):  
Leo B. A. Putte ◽  
Piet L. C. M. Riel
Keyword(s):  
Rheumatoid Arthritis ◽  
Disease Course ◽  
Disease Modifying Antirheumatic Drugs ◽  
Antirheumatic Drugs ◽  
Disease Modifying
Sign in / Sign up

Export Citation Format

Share Document